Powered by

Mycovia Pharmaceuticals, HHS Assigned Patent for Antifungal Compound Process

Aug 29, 2019 - Targeted News Service

ALEXANDRIA, Va., Aug. 29 -- Mycovia Pharmaceuticals, Durham, North Carolina, and the U.S. Department of Health and Human Services, Rockville, Maryland, have been assigned a patent (No. 10,392,365, initially filed Jan. 7, 2019) developed by six co-inventors for an antifungal compound process. The co-inventors are William J. Hoekstra, Durham, North Carolina, Christopher M. Yates, Raleigh, North Carolina, Mark Behnke, Poolesville, Maryland, Asaf Alimardanov, North Bethesda, Maryland, Scott A. David...